Racial Disparities in Hepatitis C Treatment Eligibility

Racial differences in hepatitis C treatment eligibility.

UNLABELLED Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon (PEG-IFN) plus ribavirin (RBV). The impact of race on HCV treatment eligibility is unknown. We therefore performed a retrospective analysis of a phase 3B multicenter clinical trial conducted at 118 United States community and academic ...

Racial Disparities in Treatment Rates for Chronic Hepatitis C

Chronic hepatitis C (CHC) disproportionately affects racial minorities in the United States (US). Although prior studies have reported lower treatment rates in Blacks than in Caucasians, the rates of other minorities remain understudied. We aimed to examine antiviral treatment rates by race and to evaluate the effect of other demographic, medical, and psychiatric factors on treatment rates. We ...

Racial and Ethnic Disparities in Knowledge About Hepatitis C

The aim of this study was to characterize knowledge of HCV, specifically in an urban, minority population. Methods: New patients, 18 or older, were prospectively enrolled at four primary care practices in Philadelphia. Demographics were ascertained and a survey was administered, querying HCV knowledge. Log-linear regression was used to assess the relationship between race and knowledge, measure...

Genomic variants link to hepatitis C racial disparities

Chronic liver diseases are one of the major public health issues in United States, and there are substantial racial disparities in liver cancer-related mortality. We previously identified racially distinct alterations in the expression of transcripts and proteins of hepatitis C (HCV)-induced hepatocellular carcinoma (HCC) between Caucasian (CA) and African American (AA) subgroups. Here, we perf...

Racial and ethnic disparities in depression treatment